Cost-effectiveness analysis and incremental cost-effectiveness ratios: uses and pitfalls

被引:44
作者
Bambha, K [1 ]
Kim, WR [1 ]
机构
[1] Mayo Clin & Mayo Fdn, Div Gastroenterol & Hepatol, Rochester, MN 55905 USA
关键词
cost-effectiveness; economic analysis; incremental cost-effectiveness ratio; costs; sensitivity analysis; discounting; health care costs;
D O I
10.1097/00042737-200406000-00003
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Cost-effectiveness analysis is a formal method of comparing alternative medical interventions with regard to their resource utilization (costs) and outcomes (effectiveness). The incremental cost-effectiveness ratio is an informative measure generated from such an analysis and represents the ratio of the difference in cost between two medical interventions to the difference in outcomes between the two interventions. Thus, the incremental cost-effectiveness ratio summarizes the additional cost per unit of health benefit gained in switching from one medical intervention to another. Although incremental cost-effectiveness ratios have limitations, when used in the proper context, these ratios serve as one of the important tools needed to help guide decisions about allocating scarce resources across competing medical programmes. (C) 2004 Lippincott Williams Wilkins.
引用
收藏
页码:519 / 526
页数:8
相关论文
共 50 条
  • [41] Cost-effectiveness analysis: A primer for psychologists
    Lombard, D
    Haddock, CK
    Talcott, GW
    Reynes, R
    APPLIED & PREVENTIVE PSYCHOLOGY, 1998, 7 (02) : 101 - 108
  • [42] AXIOMATIC FOUNDATIONS FOR COST-EFFECTIVENESS ANALYSIS
    Canning, David
    HEALTH ECONOMICS, 2013, 22 (12) : 1405 - 1416
  • [43] Making the leap from cost analysis to cost-effectiveness
    Pennington, Mark
    Vernazza, Chris
    Heasman, Peter
    JOURNAL OF CLINICAL PERIODONTOLOGY, 2009, 36 (08) : 667 - 668
  • [44] A cost-utility and cost-effectiveness analysis of an acute pain service
    Stadler, M
    Schlander, M
    Braeckman, M
    Nguyen, T
    Boogaerts, JG
    JOURNAL OF CLINICAL ANESTHESIA, 2004, 16 (03) : 159 - 167
  • [45] The Relative Cost-Effectiveness of Anticoagulants Obvious, Except for the Cost and the Effectiveness
    Avorn, Jerry
    CIRCULATION, 2011, 123 (22) : 2519 - 2521
  • [46] The cost-effectiveness of varicella vaccination in Canada
    Brisson, M
    Edmunds, WJ
    VACCINE, 2002, 20 (7-8) : 1113 - 1125
  • [47] Schizophrenia costs and treatment cost-effectiveness
    Knapp, M
    ACTA PSYCHIATRICA SCANDINAVICA, 2000, 102 : 15 - 18
  • [48] Interpreting the Results of Cost-Effectiveness Studies
    Cohen, David J.
    Reynolds, Matthew R.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2008, 52 (25) : 2119 - 2126
  • [49] The cost-effectiveness of biopharmaceuticals A look at the evidence
    Wilson, Andrew W.
    Neumann, Peter J.
    MABS, 2012, 4 (02) : 281 - 288
  • [50] Understanding and Anticipating Lag-Time Bias in Cost-Effectiveness Studies: The Role of Time in Cost-Effectiveness Analysis
    van de Wetering, Gijs
    Rikkert, Marcel Olde
    van der Wilt, Gert Jan
    Adang, Eddy
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2014, 30 (06) : 608 - 611